isocoumarins has been researched along with Breast Cancer in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chikkaputtaiah, C; Das, V; Deka Boruah, HP; Duarah, G; Kaishap, PP; Pal, M | 1 |
Armstrong, P; Delbederi, Z; Feutren-Burton, S; Higgins, CA; Johnston, PG; McGarel, K; McGrath, O; Mills, T; van den Berg, H; Watters, W; Waugh, D | 1 |
Di Stefano, G; Farabegoli, F; Fiume, L; Manerba, M; Roberti, M; Vettraino, M | 1 |
Agata, N; Bamberg, M; Dickerson, WM; Fram, R; Kalluri, R; Kamphaus, GD; Kharbanda, S; Kufe, D; Milhollen, M; Reimer, CL; Rook, SL; Tammam, JG | 1 |
4 other study(ies) available for isocoumarins and Breast Cancer
Article | Year |
---|---|
Cytotoxic and apoptosis-inducing effects of novel 8-amido isocoumarin derivatives against breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Survival; Cytotoxins; Dose-Response Relationship, Drug; Humans; Isocoumarins; MCF-7 Cells | 2021 |
Synthesis and in vitro and in vivo evaluation of a series of dihydroisocoumarin derivatives conjugated with fatty acids, alcohols, and amines as potential anticancer agents.
Topics: Alcohols; Amines; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Fatty Acids; Humans; Isocoumarins; Melanoma; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2009 |
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.
Topics: Apoptosis; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Energy Metabolism; Female; Glucose; Glycolysis; Humans; Isocoumarins; L-Lactate Dehydrogenase; Lymphocytes; MCF-7 Cells; Oxidative Stress; Oxygen Consumption; Signal Transduction | 2012 |
Antineoplastic effects of chemotherapeutic agents are potentiated by NM-3, an inhibitor of angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Aorta; Breast Neoplasms; Cell Movement; Coumarins; Cyclophosphamide; Drug Synergism; Endothelium, Vascular; Female; Fluorouracil; Growth Inhibitors; Humans; Isocoumarins; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Paclitaxel; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Xenograft Model Antitumor Assays | 2002 |